Ara
Toplam kayıt 18, listelenen: 1-10
A Rare Cause of Pruritus That is Seen Frequently in Hemodialysis Patients: Kyrle's Disease
(TURK NEFROLOJI DIYALIZ TRANSPLANTASYON DERGISI, 2016)
Uremic pruritus is a common complication of chronic renal failure. It affects approximately half of patients undergoing dialysis treatment. Even if the pruritus is not hazardous alone, it causes physical and mental fatigue, ...
The incidence of new onset diabetes after transplantation and related factors: Single center experience
(SOC ESPANOLA NEFROLOGIA DR RAFAEL MATESANZ, 2017)
Aim: New-onset diabetes after transplantation (NODAT) is a frequent metabolic complication and is considered a risk factor for patients undergoing renal transplant. The aim of this study was to evaluate the incidence and ...
Evaluation of Physical Activity with a Pedometer in Hemodialysis Patients
(TURK NEFROLOJI DIYALIZ TRANSPLANTASYON DERGISI, 2018)
OBJECTIVE: It has been shown that the physical activity of those with chronic illness is decreased. We aimed to evaluate the daily physical activities of hemodialysis (HD) patients with a pedometer. MATERIAL and METHODS: ...
Factors Affecting Registration on Kidney Transplant Waiting List
(2019)
Objective: This study aimed to determine the rate of registration on a kidney transplant waiting list and to investigate related factors in our geographical region. Materials and Methods: We conducted this study with 355 ...
The Dialysis Outcomes and Practice Patterns Study (DOPPS) in Turkey
(WILEY, 2017)
Introduction: Turkey has one of the largest treated end-stage renal disease (ESRD) patient populations in Europe (N=66,711). In 2013, the international Dialysis Outcomes and Practice Patterns Study (DOPPS), a prospective ...
New-Onset Diabetes After Kidney Transplantation and Pretransplant Hypomagnesemia
(SAGE PUBLICATIONS INC, 2016)
Aim: Hypomagnesemia is a frequent finding in kidney transplant patients and plays a causal role in insulin resistance and diabetes. The aim of this study was to investigate whether the pretransplant magnesium (Mg) level ...
Statins in the treatment of autosomal dominant polycystic kidney disease
(OXFORD UNIV PRESS, 2016)
aEuro broken vertical bar Will statins take a place in the therapeutic armamentarium of ADPKD? We need large randomized controlled trials to give a clear answer to this question. Until we get this evidence, the decision ...
Renal and metabolic effects of valsartan
(TURKISH SOC CARDIOLOGY, 2014)
It is known that the drugs which suppress the renin-angiotensin-aldosterone system can prevent target organ damage, independent of their blood pressure lowering effects. Besides, it has been reported that this group of ...
Do Hemodialysis Patients Aware of the Importance of Using Home Sphygmomanometer?
(TURK NEFROLOJI DIYALIZ TRANSPLANTASYON DERGISI, 2019)
Objective: We investigated the prevalence of patients owning a home sphygmomanometer among patients on hemodialysis, the type of home sphygmomanometer, the factors that affect owning a device, and the frequency of home ...
European ADPKD Forum multidisciplinary position statement on autosomal dominant polycystic kidney disease care
(OXFORD UNIV PRESS, 2018)
Autosomal dominant polycystic kidney disease (ADPKD) is a chronic, progressive condition characterized by the development and growth of cysts in the kidneys and other organs and by additional systemic manifestations. ...